The $267M loan increase and maturity extension remove near-term refinancing risk and provide capital to execute the Lila Sciences build-out. The key catalyst is the December 31, 2026 deadline for Conversion Component completion — a miss triggers an Event of Default. Monitor progress against that milestone and the Lila Lease delivery schedule.
Price Chart
Executive Summary
IIPR's borrower, IQHQ-Alewife Holdings, LLC, entered into a $267M loan increase (Note B: $245M from IIP Life Science Investments II LLC; Note C: $22M from NREF OP IV Subholdco, LLC), bringing the total mezzanine loan to $400M. The proceeds will repay an $85M bridge loan and fund tenant improvements for Lila Sciences. The initial maturity was extended to February 9, 2028, with a second extension option tied to a 6.75% debt yield test. This is a large, credit-positive capital injection that resolves near-term liquidity and funds a major pre-leased build-out.
Key Financial Metrics
Key Facts
- Total mezzanine loan increased from $133M to $400M via a $267M Loan Increase
- Note A-2 (IIP Life Science Investments II LLC) commits $245M; Note A-3 (NREF OP IV Subholdco, LLC) commits $22M
- Proceeds repay an $85M bridge loan and fund tenant improvements for Lila Sciences (Lila Lease)
- Initial maturity extended to February 9, 2028 (First Extension Option exercised)
- Second Extension Option requires a Maturity Extension Debt Yield (Aggregate) of at least 6.75%
- Exit Fee increased from 0.50% to 1.0% of the repaid amount
- Component Substantial Completion of the Conversion Component must occur by December 31, 2026, or an Event of Default occurs
Financial Impact
Loan increase of $267M, total facility now $400M. Repays $85M bridge loan. Funds tenant improvements for Lila Sciences.
Risk Factors
- Failure to achieve Component Substantial Completion of the Conversion Component by December 31, 2026 triggers an Event of Default
- Second Extension Option requires a 6.75% debt yield, which may be challenging if leasing lags
- Large loan increase adds significant leverage ($400M mezzanine + senior mortgage) on a single-asset project
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-112568 |
| Document: tm2626535d1_ex10-3.htm | 0001104659-26-112568 |
| Document: tm2626535d1_ex10-1.htm | 0001104659-26-112568 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 8-K | $53.20 $54.56 | ▲ +2.56% | ▲ +3.57% | $53.36 (+0.30%) |
Oct 13, 2026 14d ago | Insider Buy | $51.43 $52.58 | ▲ +2.24% | ▲ +1.78% | $53.36 (+3.75%) |
Oct 9, 2026 17d ago | 424B5 | $51.19 $51.61 | ▲ +0.82% | ▲ +2.31% | $53.36 (+4.24%) |
Oct 7, 2026 20d ago | 424B5 | $51.23 $51.43 | ▼ −0.39% | ▼ −1.37% | $53.36 (−4.16%) |
Oct 1, 2026 26d ago | 8-K | $51.00 $51.92 | ▲ +1.80% | ▲ +0.50% | $53.36 (+4.63%) |
Jul 21, 2026 14w ago | 8-K | $63.26 $61.42 | ▲ +2.91% | ▲ +1.68% | $53.36 (+15.65%) |
Jun 15, 2026 19w ago | 8-K | $59.60 $60.66 | ▲ +1.78% | ▲ +4.01% | $53.36 (−10.47%) |
Jun 11, 2026 19w ago | 8-K | $60.49 $59.60 | ▼ −1.47% | ▼ −2.14% | $53.36 (−11.79%) |
Jun 9, 2026 19w ago | 8-K | $23.90 $24.35 | ▲ +1.88% | ▼ −0.26% | $53.36 (+123.26%) |
May 22, 2026 22w ago | 424B5 | $23.88 $24.10 | ▼ −0.92% | ▲ +0.29% | $53.36 (−123.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers